Kanya Honoki Selected Research

Giant Cell Tumors (Giant Cell Tumor)

5/2022	Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
12/2021	Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum.
9/2020	Denosumab for Bone Giant Cell Tumor of the Distal Radius.
6/2019	Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation.
1/2019	Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
11/2017	Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kanya Honoki Research Topics

Disease

51	Neoplasms (Cancer) 08/2022 - 02/2002
15	Neoplasm Metastasis (Metastasis) 08/2022 - 09/2007
15	Osteosarcoma (Osteogenic Sarcoma) 05/2022 - 02/2002
13	Carcinogenesis 08/2022 - 02/2006
12	Adenocarcinoma 05/2020 - 08/2005
11	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 09/2007
11	Adenocarcinoma of Lung 08/2011 - 01/2004
6	Giant Cell Tumors (Giant Cell Tumor) 05/2022 - 11/2017
6	Giant Cell Tumor of Bone 05/2022 - 11/2017
5	Hepatocellular Carcinoma (Hepatoma) 04/2013 - 04/2007
5	Malignant Fibrous Histiocytoma 01/2008 - 02/2002
4	Fibrosarcoma 01/2018 - 01/2010
4	Hypoxia (Hypoxemia) 12/2015 - 10/2012
3	Breast Neoplasms (Breast Cancer) 08/2018 - 01/2010
2	Spontaneous Fractures (Pathological Fracture) 05/2022 - 06/2019
2	Necrosis 01/2022 - 12/2015
2	Stress Fractures (Stress Fracture) 12/2021 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2018 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 02/2018 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2010
2	Lung Neoplasms (Lung Cancer) 03/2016 - 10/2007
2	Ewing Sarcoma (Sarcoma, Ewing) 09/2007 - 11/2006
1	Colorectal Neoplasms (Colorectal Cancer) 08/2022
1	Lacerations 12/2021
1	Osteonecrosis (Kienbock's Disease) 12/2021
1	Granuloma 12/2021
1	Infections 12/2021
1	Stomach Neoplasms (Stomach Cancer) 05/2021
1	Lymphatic Metastasis 05/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2020
1	Margins of Excision 05/2020
1	Granular Cell Tumor 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 09/2018

Drug/Important Bio-Agent (IBA)

14	lysophosphatidic acidIBA 01/2018 - 01/2009
13	Lysophosphatidic Acid ReceptorsIBA 08/2018 - 10/2006
9	hydrogen sulfite (bisulfite)IBA 08/2011 - 08/2005
8	diisopropanolnitrosamineIBA 01/2010 - 02/2006
6	Denosumab FDA Link 12/2021 - 11/2017
6	Biological ProductsIBA 11/2021 - 02/2002
5	RNA (Ribonucleic Acid)IBA 10/2007 - 02/2006
4	CytokinesIBA 05/2021 - 02/2002
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 03/2016
4	Pharmaceutical PreparationsIBA 01/2018 - 03/2016
4	nitrosobis(2-oxopropyl)amine (NBOP)IBA 10/2009 - 10/2005
4	Drinking WaterIBA 10/2007 - 02/2006
3	GTP-Binding Proteins (G-Protein)IBA 01/2018 - 03/2016
3	PhytochemicalsIBA 12/2015 - 12/2015
3	CDAA (Randox)IBA 01/2009 - 04/2007
3	Cadherins (E-Cadherin)IBA 04/2007 - 10/2005
2	HMGB1 Protein (HMG1)IBA 08/2022 - 05/2021
2	Durapatite (Hydroxylapatite)IBA 05/2022 - 02/2008
2	Diphosphonates (Bisphosphonates)IBA 11/2021 - 07/2011
2	Proteins (Proteins, Gene)FDA Link 05/2021 - 12/2015
2	Dihydrotachysterol (AT 10)IBA 05/2020 - 08/2013
2	ChemokinesIBA 09/2018 - 01/2012
2	Nonesterified Fatty Acids (NEFA)IBA 11/2016 - 03/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2015 - 12/2015
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2015 - 05/2004
2	ResveratrolIBA 12/2015 - 12/2015
2	Drug CombinationsIBA 12/2015 - 12/2015
2	Interleukin-6 (Interleukin 6)IBA 10/2012 - 02/2002
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2012 - 01/2012
2	extracellular matrix receptorIBA 01/2012 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 10/2007
2	Choline (Choline Chloride)IBA 10/2007 - 04/2007
2	Amino Acids FDA Link 10/2007 - 04/2007
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2007 - 07/2007
2	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2007 - 01/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 07/2006 - 02/2002
2	Protein Isoforms (Isoforms)IBA 02/2006 - 02/2002
1	Bone Cements (Bone Glue)IBA 05/2022
1	Polymethyl Methacrylate (Sol)IBA 05/2022
1	LectinsIBA 02/2022
1	ontuxizumabIBA 02/2022
1	Fibronectins (Fibronectin)IBA 02/2022
1	C-Type Lectins (C-Type Lectin)IBA 02/2022
1	Monoclonal AntibodiesIBA 02/2022
1	Interferon-alpha (Interferon Alfa)IBA 11/2021
1	ThapsigarginIBA 05/2021
1	Fluorouracil (Carac)FDA LinkGeneric 05/2021
1	Glucose (Dextrose)FDA LinkGeneric 05/2021
1	Glyoxal (Ethanedial)IBA 05/2021
1	pterostilbeneIBA 12/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2019
1	Conditioned Culture MediaIBA 09/2018
1	Chemokine CCL26IBA 09/2018
1	matrigelIBA 08/2018
1	Tamoxifen FDA LinkGeneric 08/2018

Therapy/Procedure

10	Therapeutics 08/2022 - 07/2011
6	Drug Therapy (Chemotherapy) 11/2021 - 02/2008
6	Radiotherapy 11/2021 - 08/2013
4	Adjuvant Chemotherapy 05/2022 - 05/2020
4	Curettage 05/2022 - 02/2006
1	Transplantation 08/2022
1	Bone Transplantation (Bone Grafting) 05/2022
1	Free Tissue Flaps 01/2022
1	Operative Time 01/2022
1	Metastasectomy 11/2021
1	Neoadjuvant Therapy 05/2021